NCT00585104View on ClinicalTrials.gov

Myocardial Hemodynamic Effects of Levosimendan

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Heart Failure
Interventions
DRUG

levosimendan

10-minute infusion

Trial Locations (1)

84112

University of Utah, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER

NCT00585104 - Myocardial Hemodynamic Effects of Levosimendan | Biotech Hunter | Biotech Hunter